EOM Pharmaceuticals Holdings, Inc.
IMUC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $19,429 | $26,279 | $92,848 | $19,081 |
| - Cash | $99 | $278 | $613 | $1,487 |
| + Debt | $442 | $4,735 | $3,467 | $2,817 |
| Enterprise Value | $19,772 | $30,736 | $95,702 | $20,412 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$929 | -$999 | -$2,207 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$1,892 | -$1,613 | -$2,647 | -$2,679 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.016 | -0.014 | -0.023 | -0.059 |
| % Growth | -15.5% | 39.3% | 60.3% | – |
| Operating Cash Flow | -$2,680 | -$1,422 | -$2,623 | -$2,306 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$2,680 | -$1,422 | -$2,623 | -$2,306 |